RECURSION PHARMACEUTICALS, INC. (RXRX): Submission of Matters to a Vote of Security Holders
RECURSION PHARMACEUTICALS, INC. (RXRX) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. rxrx-20260617 0001601830 FALSE 0001601830 2026-06-17 2026-06-17 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported):
How this was made
The 30-second read
Why it matters
The disclosure confirms that two Class II directors were elected, the advisory resolution on executive compensation passed, and PricewaterhouseCoopers LLP was ratified as independent auditor for 2026.
Market read
This is a routine governance/proxy outcome filing; it is unlikely to drive a new trading thesis absent a contested or failed vote.
What to watch
Traders may still monitor whether any director election was close or whether compensation approval was contentious, but the filing provides no qualitative context beyond vote counts.
Background
The SEC 8-K reports results of Recursion Pharmaceuticals’ June 17, 2026 annual stockholder meeting, referencing the April 30, 2026 proxy statement.
Ticker impact
Recursion Pharmaceuticals disclosed 2026 annual meeting voting results, including director elections, say-on-pay approval, and auditor ratification.
Low near-term impact; any reaction likely muted unless investors were focused on governance/auditor changes.
The filing reports standard proxy vote tallies (board election, advisory compensation, PwC ratification) without indicating contested outcomes or material corporate actions.
Market effects
Minimal; this is company-specific governance disclosure with no sector-wide regulatory or clinical read-through.
None.
None.
Counterpoint
If there had been a failed say-on-pay or auditor ratification, it could have raised governance/audit risk; however, the votes shown indicate approval/ratification.
Key entities
- companyRecursion Pharmaceuticals, Inc.
Subject of the SEC 8-K; reported annual meeting voting outcomes (board, say-on-pay, auditor ratification).
- auditorPricewaterhouseCoopers LLP
Ratified as independent registered public accounting firm for the year ending December 31, 2026.
